DiaMedica Therapeutics Inc. of MINNEAPOLIS, MN, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-17. The offering totals $344K, of which $201K was reported sold. Industry: Biotechnology.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| Michael Giuffre | Director | Minneapolis, MN |
| James Parsons | Director | Mississauga, A6 |
| Richard Pilnik | Director | Houston, TX |
| Zhenyu Jerry Xiao | Director | Minneapolis, MN |
| David Gurvey | Executive Officer | Minneapolis, MN |
| Paul Papi | Executive Officer | Minneapolis, MN |
| Todd Verdoorn | Executive Officer | Minneapolis, MN |
| David J Wambeke | Executive Officer | Minneapolis, MN |
| Charles P Semba | Director | Minneapolis, MN |
| Lorianne Masuoka | Executive Officer | Minneapolis, MN |
| Daniel T O'Connor | Director | Minneapolis, MN |
| Scott Kellen | Executive Officer | Minneapolis, MN |
| Richard R Kuntz | Director | Minneapolis, MN |
| Michael R Giuffre | Director | Minneapolis, MN |
| Tanya N Lewis | Director | Minneapolis, MN |
| Rick Pauls | Director | Minneapolis, MN |
| Rick Pauls | Executive Officer | Minneapolis, MN |
| James T Parsons | Director | Minneapolis, MN |
| Richard Michael Kuntz | Director | Minneapolis, MN |
| R. Michael Giuffre | Director | Minneapolis, MN |
| Richard D Pilnik | Director | Minneapolis, MN |
| Dominic Cundari | Executive Officer | Minneapolis, MN |
| Julie Daves | Executive Officer | Minneapolis, MN |
| Kirsten Gruis | Executive Officer | Minneapolis, MN |
| Richard P Kuntz | Director | Minneapolis, MN |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-07-25 | D | $30.1M | $30.1M |
| 2024-07-02 | D | $11.8M | $11.8M |
| 2023-06-27 | D | $37.5M | $37.5M |
| 2023-04-18 | D | $750K | $750K |
| 2021-10-06 | D | $30.0M | $30.0M |